If you have been reading about lyophilisation and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Last reviewed on 2025-11-26. Where a claim depends on a specific study, the study is described rather than over-claimed.
Proposed mechanisms include interaction with the nitric oxide system, modulation of growth factor signaling, and effects on blood vessel formation. None of these has been established as the primary mode of action, and some proposed pathways rest on indirect measurements. Whether the reported effects depend on a specific receptor has not been determined. Stability in gastric acid, unusual for a peptide of this size, is also reported in animal work, but the reason for it is not firmly established.
Published studies on BPC-157 are dominated by animal models. Commonly used endpoints include healing of surgically induced lesions in the stomach, tendon-to-bone attachment after transection, and recovery from experimentally induced vascular or intestinal damage. Many of these reports come from a small number of research groups, and the peptide is often described as acting across a wide range of tissue types. That breadth is itself a point of discussion, since one molecule influencing many unrelated systems is unusual.
The main chemical liabilities of this sequence are peptide-bond hydrolysis and possible aspartate-related reactions, since the peptide contains aspartic acid residues but no cysteine, methionine, or tryptophan. Absence of those three residues removes the most common oxidation and disulfide pathways from consideration. Studies of related peptides indicate that aspartate isomerisation and aspartimide formation occur most readily at Asp-Gly and Asp-Ala positions, and open questions remain about how quickly those reactions proceed under ordinary laboratory conditions. Storage guidance typically emphasises cool, dry, dark conditions to slow hydrolysis.
Identity and purity are usually assessed with reversed-phase high-performance liquid chromatography, often paired with mass spectrometry using electrospray or MALDI ionisation. Amino acid analysis and peptide mapping by enzymatic digestion provide additional sequence-level confirmation. Purity is commonly reported as an area percentage from a chromatographic trace, and water content can be measured by Karl Fischer titration. Reported masses may differ by tens of daltons between sources because preparations can contain acetate or trifluoroacetate counterions, and such differences are not by themselves evidence of a different peptide.
BPC-157 is normally distributed as a lyophilised powder that ranges from white to off-white in appearance. The peptide dissolves readily in water, normal saline, and common aqueous buffers, and it is poorly soluble in nonpolar solvents such as hexane or vegetable oils. Lyophilised vials take up moisture if left open, which changes the mass of powder in the container and complicates any later weighing. Because the material is handled in small quantities, static and adhesion to glass or plastic can also cause noticeable losses during transfer.
| Property | Value | Notes |
|---|---|---|
| Study species | Rodents, mainly rats | Most reports use surgically induced injury models |
| Typical administration route | Subcutaneous or intraperitoneal injection | Routes differ between reports, which complicates comparison |
| Human trial evidence | Limited, small-scale reports | No large randomized trial in indexed journals |
| Reported outcome categories | Mucosal healing, tendon repair, vascular recovery | Endpoints are not standardized across studies |
| Mechanism status | Not established | Proposed pathways lack direct confirmation |
Identity and purity are established with complementary methods rather than one test. Reverse-phase high-performance liquid chromatography separates the main peak from deletion sequences and oxidized variants, and its area percentage is the usual purity figure. Mass spectrometry confirms the expected molecular mass and can flag truncations or modifications that chromatography alone might miss. Amino acid analysis and peptide mapping add sequence-level confirmation, while residual counter-ion and water content are measured separately.
A freeze-dried sample is generally the most stable form and is commonly held at minus twenty degrees Celsius or lower for long-term keeping, with brief transfers at room temperature. The solid is hygroscopic, so vials are warmed to ambient temperature before opening to prevent condensation from degrading the contents. Light exposure and repeated temperature cycling are both avoided in routine handling. Storage over a desiccant is a common laboratory practice that limits moisture uptake during repeated access.
Supplied material is typically a lyophilized white to off-white powder. The peptide is freely soluble in water and in common aqueous buffers, which allows it to be handled as a stock solution. Because the sequence contains no cysteine, disulfide cross-linking is not a route of degradation. The absence of aromatic residues means ultraviolet absorbance at 280 nm is minimal, so quantification usually relies on peptide bond absorbance near 214 nm or on amino acid analysis.
Common synonyms in catalogs include pentadecapeptide BPC 157, BPC157, and the full sequence name. A CAS registry number in the 137525-51-0 range is frequently listed, though the assignment should be verified against the supplier certificate of analysis. The name itself is not a pharmacopoeial designation, and there is no standardized international nonproprietary name. Distinguishing genuine material from related fragments generally requires mass spectrometry, since several truncated sequences share similar chromatographic behavior.
BPC-157 is a synthetic peptide composed of fifteen amino acid residues, with the sequence Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val. Its name derives from body protection compound, a term used for a protein fraction identified in human gastric juice. Researchers in Zagreb first reported the pentadecapeptide in the early 1990s and described it as a stable fragment of that larger protein. The compound is also catalogued as PL 14736 and, in some commercial contexts, as bepecin. Its molecular formula is C62H98N16O22 and its monoisotopic mass is approximately 1419 daltons.
Most published work on BPC-157 consists of preclinical studies, including rodent models of tissue injury, gastrointestinal lesions, and vascular or tendon damage, together with in vitro cell assays. Reviews frequently note that the mechanisms proposed in these papers remain incompletely characterised and that findings have not been confirmed in large randomised human trials. The compound is widely sold as a research chemical rather than a licensed medicine, and labels commonly carry a statement that it is not for human use. Whether any of the reported animal effects translate to humans is an open question rather than an established result.
=== Labeling === For U.S. food and dietary supplement labeling purposes, the amount in a serving is expressed as a percent of Daily Value (%DV). For molybdenum labeling purposes, 100% of the Daily Value was 75 μg, but as of May 27, 2016 it was revised to 45 μg. A table of the old and new adult daily values is provided at Reference Daily Intake.
Tho told Kissinger that the Khmer Rouge's leader, Pol Pot, was a Vietnamphobe and that North Vietnam had very limited influence over him. At the same time, Kissinger reported to Nixon that "only a miracle" could save South Vietnam now, as Thiệu showed no signs of making the necessary reforms to allow the ARVN to fight. His assessment of Cambodia was even bleaker, as the Lon Nol regime had lost control of much of the countryside by the spring of 1973, and only American air strikes prevented the Khmer Rouge from taking Phnom Penh. Between March–May 1973, American bombers dropped 95,000 tons of bombs on Cambodia, while American fighters dropped another 15,000 tons of bombs. On 4 June 1973, the Senate passed a bill that already cleared the House of Representatives to block funding for any American military operations in Indochina, and Kissinger spent much of the summer of 1973 lobbying Congress to extend the deadline to 15 August in order to keep bombing Cambodia. The Lon Nol regime was saved in 1973 due to heavy American bombing, but the cutoff in funding ended the possibility of an American return to Southeast Asia. The PAVN had taken heavy losses in the Easter Offensive, but the North Vietnamese were rebuilding their strength for a new offensive. By the spring of 1973, Nixon was caught up in the Watergate scandal and was losing interest in foreign affairs. Kissinger was angry that the Secretary of State, William Rogers, had not resigned so he take could over the State Department, shouting: "And now's he's hanging on just as I said he would. Piece by piece. Bit by bit.
Heparin-binding EGF-like growth factor (HB-EGF) is a member of the EGF family of proteins that in humans is encoded by the HBEGF gene. HB-EGF-like growth factor is synthesized as a membrane-anchored mitogenic and chemotactic glycoprotein. An epidermal growth factor produced by monocytes and macrophages, due to an affinity for heparin is termed HB-EGF. It has been shown to play a role in wound healing, cardiac hypertrophy, and heart development and function. First identified in the conditioned media of human macrophage-like cells, HB-EGF is an 87-amino acid glycoprotein that displays highly regulated gene expression. Ectodomain shedding results in the soluble mature form of HB-EGF, which influences the mitogenicity and chemotactic factors for smooth muscle cells and fibroblasts. The transmembrane form of HB-EGF is the unique receptor for diphtheria toxin and functions in juxtacrine signaling in cells. Both forms of HB-EGF participate in normal physiological processes and in pathological processes including tumor progression and metastasis, organ hyperplasia, and atherosclerotic disease. HB-EGF can bind two locations on cell surfaces: heparan sulfate proteoglycans and EGF-receptors effecting cell-to-cell interactions.
== Further reading == Virginia Ott (November 1976). Man with a Million Ideas: Fred Jones, Genius/Inventor. Lerner Publications Company. ISBN 978-0-822-50761-1. Gloria M. Swanson, Margaret V. Ott (1994). I've Got an Idea: The Story of Frederick McKinley Jones (reprint ed.). Lerner Publishing Group. p. 95. ISBN 0-82259-662-8.
Sources: en.wikipedia.org
The spontaneous decay of free protons has never been observed, and protons are therefore considered stable particles according to the Standard Model. However, some grand unified theories (GUTs) of particle physics predict that proton decay should take place with lifetimes between 1031 and 1036 years. The experimental lower bound for the mean lifetime is 0.96×1030 years. The mean lifetime measures decay to any product. Lifetimes for decay to specific products is also measured. For example, experiments at the Super-Kamiokande detector in Japan gave lower limits for proton mean lifetime of 1.6×1034 years for decay to an antimuon and a neutral pion, and 2.4×1034 years for decay to a positron and a neutral pion. Protons are known to transform into neutrons through the process of electron capture (also called inverse beta decay). For free protons, this process does not occur spontaneously but only when energy is supplied. The equation is:
=== Measuring Protein Synthesis === Ribo-Seq can also be used to estimate translation efficiency, a proxy for protein synthesis. For this application, ribosome profiling and matched RNA sequencing data are generated. The initial data analyses can be achieved by dedicated computational frameworks (ex.). Translation efficiency can then be computed as the ribosome occupancy of each gene while controlling for its RNA expression. This approach can be coupled with directed disruption of proteins that bind to RNA and using ribosome profiling to measure the difference in translation. These disrupted mRNAs can be associated with proteins, whose binding sites have already been mapped on RNA, to indicate regulation.
Using a long capillary tube, and including potassium chloride aerosols in the helium gas, the mendelevium atoms can be transported over tens of meters to be chemically analysed and have their quantity determined. The mendelevium can then be separated from the foil material and other fission products by applying acid to the foil and then coprecipitating the mendelevium with lanthanum fluoride, then using a cation-exchange resin column with a 10% ethanol solution saturated with hydrochloric acid, acting as an eluant. However, if the foil is made of gold and thin enough, it is enough to simply dissolve the gold in aqua regia before separating the trivalent actinides from the gold using anion-exchange chromatography, the eluant being 6 M hydrochloric acid. Mendelevium can finally be separated from the other trivalent actinides using selective elution from a cation-exchange resin column, the eluant being ammonia α-HIB.< Using the gas-jet method often renders the first two steps unnecessary. Another possible way to separate the trivalent actinides is via solvent extraction chromatography using bis-(2-ethylhexyl) phosphoric acid (abbreviated as HDEHP) as the stationary organic phase and nitric acid as the mobile aqueous phase. The actinide elution sequence is reversed from that of the cation-exchange resin column, so that the heavier actinides elute later.
Parathyroid hormone is metabolised in the liver and to a lesser extent in the kidney. It is not excreted from the body in its intact form. Circulating carboxy-terminal fragments are filtered by the kidney, but are subsequently broken down into even smaller fragments during tubular reuptake. No studies have so far been performed in patients with severe hepatic impairment. The pharmacokinetics of parathyroid hormone in patients with severe chronic kidney disease (creatinine clearance of less than 30 ml/min) has not been investigated either.
=== Opposition: 1975–79 === Heseltine did not work easily with women as senior colleagues, as was shown by the difficulty experienced by Elinor Goodman in obtaining promotion from secretary to journalist at Campaign, and his reluctance to let Josephine Hart sit on the Haymarket Board. Heseltine fully expected to be sacked from the Shadow Cabinet by the new leader (as Peter Walker was at this time), but was retained, in part because Thatcher was impressed by his fierce opposition to Benn's Industry Bill, and partly because a senior figure, possibly Geoffrey Howe, argued for his retention. Heseltine first emerged as a platform orator at the Conservative National Council in March 1975, and then at the autumn conferences in 1975 and 1976 (where he likened Labour to a one-legged army marching "Left, left, left"). He dictated his speech ideas beforehand to his scriptwriters, who had to discard a good deal of unintelligible material. His reputation was derived not from any factual content or argument, but from the force and brio of his delivery – it was said of him that he could "find the party's clitoris". There was talk of his being appointed Party Chairman (in charge of the party organisation and of campaigning across the country) in place of Peter Thorneycroft. In the summer of 1975, Heseltine persuaded the Shadow Cabinet not to oppose the Labour Government's bailout of British Leyland because of the risk to marginal seats (including some Cowley workers in northern wards of his own Henley seat).
Sources: en.wikipedia.org
It is not authorized as a medicine in the United States or the European Union. Regulatory treatment varies by jurisdiction, and in several places it is handled as a research chemical. Therapeutic claims are not supported by large human trials.
Human evidence is sparse and comes from small reports rather than large trials. Sample sizes are generally too small to support firm conclusions. The published record does not contain an independently replicated randomized trial.
Several pathways have been proposed, including effects on nitric oxide signaling and vessel formation. Direct confirmation of a primary molecular target is lacking. Some findings rest on indirect measurements, which leaves the mechanism an open question.
Lyophilised peptide powders are generally kept frozen or refrigerated, dry, and protected from light. Sealed vials limit moisture uptake and slow hydrolysis. Such guidance comes from general peptide chemistry rather than from stability studies specific to every product.